HB 4034, which was signed into law on March 23, includes several provisions of interest including allowing a pharmacy intern to transfer a drug containing pseudoephedrine or ephedrine to a person 18 years of age or older without prescription; reporting of information regarding dispensing of biological products; clarifying the use of telepharmacy and permitting a pharmacist to delegate to a pharmacy technician final verification of prescribed drug and drug dosage, device, or product  

Also in Oregon, the Board of Pharmacy has adopted the following rules:  

April 22, 2022, Temporary Rules Noticed Pursuant to 2022 HB 4034 (Signed by Gov. Kate Brown (D) on March 23, 2022) – Effective April 22, 2022 through October 18, 2022 

The Board also permanently adopted the following rules – effective April 20, 2022 – at the April 2022 Board Meeting:  

Finally in Oregon, the Oregon Health Authority issued a temporary rule, effective April 27, 2022, through June 25, 2022, amending prior authorization approval criteria guide effective May 1, 2022. These amendments are based upon Pharmacy & Therapeutics (P&T) Committee recommendations on April 7. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.